The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term
Open accessAbstract
BACKGROUND: Prostaglandins have been used for induction of labour since the 1960s. This is one of a series of reviews evaluating methods of induction of labour. This review focuses on prostaglandins given per vaginam, evaluating these in comparison with placebo (or expectant management) and with each other; prostaglandins (PGE2 and PGF2a); different formulations (gels, tablets, pessaries) and doses. OBJECTIVES: To determine the effects of vaginal prostaglandins E2 and F2a for third trimester cervical ripening or induction of labour in comparison with placebo/no treatment or other vaginal prostaglandins (except misoprostol). SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (1 March 2014) and bibliographies of relevant papers. SELECTION CRITERIA: Clinical trials comparing vaginal prostaglandins used for third trimester cervical ripening or labour induction with placebo/no treatment, with each other, or other methods listed above it on a predefined list of labour induction methods. DATA COLLECTION AND ANALYSIS: We assessed studies and extracted data independently. MAIN RESULTS: Seventy randomised controlled trials (RCTs) (11,487 women) are included. In this update seven new RCTs (778 women) have been added. Two of these new trials compare PGE2 with no treatment, four compare different PGE2 formulations (gels versus tablets, or sustained release pessaries) and one trial compares PGF2a with placebo. The majority of trials were at unclear risk of bias for most domains.Overall, vaginal prostaglandin E2 compared with placebo or no treatment probably reduces the likelihood of vaginal delivery not being achieved within 24 hours. The risk of uterine hyperstimulation with fetal heart rate changes is increased (4.8% versus 1.0%, risk ratio (RR) 3.16, 95% confidence interval (CI) 1.67 to 5.98, 15 trials, 1359 women). The caesarean section rate is probably reduced by about 10% (13.5% versus 14.8%, RR 0.91, 95% CI 0.81 to 1.02, 36 trials, 6599 women). The overall effect on improving maternal and fetal outcomes (across a variety of measures) is uncertain.PGE2 tablets, gels and pessaries (including sustained release preparations) appear to be as effective as each other, small differences are detected between some outcomes, but these maybe due to chance. AUTHORS' CONCLUSIONS: Prostaglandins PGE2 probably increase the chance of vaginal delivery in 24 hours, they increase uterine hyperstimulation with fetal heart changes but do not effect or may reduce caesarean section rates. They increase the likelihood of cervical change, with no increase in operative delivery rates. PGE2 tablets, gels and pessaries appear to be as effective as each other, any differences between formulations are marginal but may be important.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,175
Published by John Wiley & Sons Ltd
Modarresi, O. A. F., & Shakibaie, M. M. M. R. (2015) · Cited by 1,111
Induction of labour for improving birth outcomes for women at or beyond term
Middleton, P., Shepherd, E., & Crowther, C. A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004945.pub4 · Cited by 667
Mechanical methods for induction of labour
Jozwiak, M., Bloemenkamp, K. W., Kelly, A. J., Mol, B. W. J., Irion, O., & Boulvain, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001233.pub2 · Cited by 536
Self-citationInduction of Labor Compared with Expectant Management for Prelabor Rupture of the Membranes at Term
Hannah, M. E., Ohlsson, A., Farine, D., Hewson, S. A., Hodnett, E. D., Myhr, T. L., Wang, E. E. L., Weston, J. A., & Willan, A. R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604183341601 · Cited by 524
Vaginal misoprostol for cervical ripening and induction of labour
Hofmeyr, G. J., Gülmezoglu, A. M., & Pileggi, C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000941.pub2 · Cited by 510
Induction of labour for improving birth outcomes for women at or beyond term
Gülmezoglu, A. M., Crowther, C. A., Middleton, P., & Heatley, E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004945.pub3 · Cited by 411
Ml, B., & Davis, A. R. (1980) · PubMed · Cited by 367
Cited by
Boers, K. E., Vijgen, S. M. C., Bijlenga, D., van der Post, J. A. M., Bekedam, D. J., Kwee, A., van der Salm, P. C. M., van Pampus, M. G., Spaanderman, M. E. A., de Boer, K., et al. (2010) · BMJ · doi:10.1136/bmj.c7087 · Cited by 539
Mechanical methods for induction of labour
Jozwiak, M., Bloemenkamp, K. W., Kelly, A. J., Mol, B. W. J., Irion, O., & Boulvain, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001233.pub2 · Cited by 536
Self-citationVaginal misoprostol for cervical ripening and induction of labour
Hofmeyr, G. J., Gülmezoglu, A. M., & Pileggi, C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000941.pub2 · Cited by 510
Bioactive lipids, inflammation and chronic diseases
Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 358
Oral misoprostol for induction of labour
Alfirevic, Z., & Weeks, A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001338.pub2 · Cited by 331
Intravenous oxytocin alone for cervical ripening and induction of labour
Alfirevic, Z., Kelly, A. J., & Dowswell, T. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003246.pub2 · Cited by 255
Self-citation
Metadata
- Authors
- Thomas, J., Fairclough, A., Kavanagh, J., & Kelly, A. J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2014-06-19
- Volume
- 2014
- Issue
- 6
- Pages
- CD003101-CD003101
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1851293208
- Cited by
- 365
- References
- 35
- FWCI
- 29.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.